Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

Board Appointment

25 Nov 2014 07:00

RNS Number : 8702X
Byotrol PLC
25 November 2014
 



 

25 November 2014

 

Byotrol plc

BOARD APPOINTMENT

 

Byotrol plc ("Byotrol" or "the company", the leading AIM listed anti-microbial hygiene company, today announces the appointment of Dr Trevor Francis to its board as Chief Technology Officer with immediate effect.

 

Dr Francis has been working as a consultant to the Company in various positions over the last six years, particularly in consumer product development and commercialisation. Prior to joining Byotrol, Dr Francis spent 29 years at Unilever where he became Vice President of the Global R&D Homecare division and Head of the European Fabric Conditioners & Global Fragrance divisions.

 

Dr Francis is also a board trustee of the Liverpool School of Tropical Medicine where he serves on the Audit and Remuneration Committees.

 

Commenting on the appointment, Nicholas Martel, Chairman of Byotrol, said:

 

"We are delighted to welcome Trevor to the Board. His proven experience of delivering innovative products to market will be invaluable as we seek to consolidate on the recent improvements made within the Company."

 

The following information in relation to the appointment of Dr Francis is disclosed pursuant to Schedule 2(g) of the AIM Rules for Companies:

 

Full Name: Dr Thomas Trevor Francis

Age: 64

 

Current Directorships and Partnerships

Directorships and Partnerships held in the last five years

Tecnoform Associates Limited

None

Liverpool School of Tropical Medicine

 

Shareholding in Company

Options held over Company Shares

% Shareholding in Company post option exercise

Trevor Francis

739,846

2,250,000

1.33%

 

Dr Francis does not have a cash bonus scheme for the financial year ending 31 March 2015.

 

The options for Dr Francis have been granted in the Company's Enterprise Management Incentive Scheme.

 

There are no other matters which are required to be disclosed pursuant to Schedule 2(g) of the AIM Rules for Companies.

 

Enquiries:

 

Byotrol plc

01925 742 000

David Traynor - Chief Executive

Dawn Williams - Group Marketing Controller

 

 

finnCap Ltd

020 7220 0500

Geoff Nash

Christopher Raggett

 

 

 

Notes to Editors:

 

Byotrol plc (BYOT.L), quoted on AIM, is a leading anti-microbial technology company, operating globally in the Food, Industrial, Healthcare and Consumer sectors, providing low toxicity products with a broad-based and long-lasting efficacy across all microbial classes; bacteria, viruses, fungi, moulds, mycobacteria and algae.

Powerful, long-lasting and gentle, Byotrol's products can be used stand alone or as an ingredient within existing products, where Byotrol can significantly improve their performance in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

 

Founded in 2005, the Company has developed the technology that creates easier, safer and cleaner lives for everyone.

 

For more information, please go to www.byotrol.co.uk 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPGGMCGUPCGRC
Date   Source Headline
29th Nov 20112:35 pmRNSHolding(s) in Company
22nd Nov 20117:00 amRNSInterim Results
14th Nov 20114:40 pmRNSHolding(s) in Company
11th Nov 20119:46 amRNSHolding(s) in Company
9th Nov 20113:30 pmRNSHolding(s) in Company
7th Nov 201110:06 amRNSResult of EGM
21st Oct 20117:00 amRNSIssue of Equity to raise £2.46m
16th Sep 20117:00 amRNSChange of Adviser
21st Jul 20114:10 pmRNSResult of AGM
20th Jul 20117:00 amRNSMulti Country Contract with Rentokil
28th Jun 20112:39 pmRNSAnnual Financial Report and AGM notice
27th Jun 201112:14 pmRNSHolding(s) in Company
24th Jun 201110:53 amRNSHolding(s) in Company
21st Jun 20117:00 amRNSPreliminary Results
11th May 20117:00 amRNSDevelopment Contract with Fortune 150 Company
7th Apr 20115:20 pmRNSHolding(s) in Company
8th Feb 20117:00 amRNSAgreement with McBride on European Licence
9th Dec 20107:00 amRNSLicence Agreement with makers of Tommee Tippee
30th Nov 20102:39 pmRNSDirector/PDMR Shareholding
16th Nov 20107:00 amRNSInterim Results
23rd Sep 20105:18 pmRNSHolding(s) in Company
3rd Sep 201010:12 amRNSHolding(s) in Company
31st Aug 201012:01 pmRNSResult of General Meeting
19th Aug 201012:50 pmRNSGrant of Options
11th Aug 20107:00 amRNSIssue of Equity
29th Jul 20103:33 pmRNSResult of AGM
7th Jul 20107:00 amRNSJDA in UK & Ireland and Agreement Extension in US
6th Jul 20102:18 pmRNSAnnual Report and Notice of AGM
30th Jun 20107:00 amRNSContract to supply Odour Elimination goods in USA
25th Jun 20103:41 pmRNSDirector/PDMR Shareholding
22nd Jun 20104:02 pmRNSDirector/PDMR Shareholding
15th Jun 20107:00 amRNS2010 Preliminary Results
28th May 20107:00 amRNSResearch Grant, Patent Grant & Directorate Change
13th Apr 20101:38 pmRNSDirector/PDMR Shareholding
13th Apr 201010:16 amRNSDirector/PDMR Shareholding
30th Mar 20102:42 pmRNSDirector/PDMR Shareholding
25th Mar 201010:00 amRNSTrading update and results date
25th Mar 201010:00 amRNSDirectorate Change
26th Feb 201012:52 pmRNSTotal Voting Rights
4th Feb 20109:42 amRNSAcquisition of ByoFresh
22nd Dec 200911:40 amRNSHolding(s) in Company
22nd Dec 200911:40 amRNSHolding(s) in Company
21st Dec 20097:00 amRNSUS Patent and Option Agreement
1st Dec 20097:00 amRNSSociety of Food Hygiene & Technology Award
20th Nov 20097:00 amRNSDirector/PDMR Shareholding
17th Nov 20097:00 amRNSInterim Results
6th Oct 20097:00 amRNSTrading Statement
29th Sep 200911:59 amRNSHolding(s) in Company
17th Sep 20097:00 amRNSTrading Statement
11th Aug 20099:47 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.